Pular para o conteúdo
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Avançada
  • THROMBOCYTOSIS AS A PREDICTIVE...
  • Citar
  • Enviar por SMS
  • Enviar por e-mail
  • Imprimir
  • Exportar registro
    • Exportar para RefWorks
    • Exportar para EndNoteWeb
    • Exportar para EndNote
  • Link permanente
THROMBOCYTOSIS AS A PREDICTIVE AND PROGNOSTIC MARKER IN ADVANCED COLORECTAL CANCER (ACRC): RESULTS OF THE MRC COIN TRIAL EXPLORED

THROMBOCYTOSIS AS A PREDICTIVE AND PROGNOSTIC MARKER IN ADVANCED COLORECTAL CANCER (ACRC): RESULTS OF THE MRC COIN TRIAL EXPLORED

Detalhes bibliográficos
Principais autores: Maughan, T, Wilson, R, Seymour, M, Meade, A, Fisher, D, Kenny, S, Smith, C, Cheadle, J, Kaplan, R, Adams, R
Formato: Conference item
Publicado em: 2010
  • Itens
  • Descrição
  • Registros relacionados
  • Registro fonte

Registros relacionados

  • Addition of cetuximab to oxaliplatin-based combination chemotherapy (CT) in patients with KRAS wild-type advanced colorectal cancer (ACRC): a randomised superiority trial (MRC COIN)
    por: Maughan, T, et al.
    Publicado em: (2009)
  • ADDITION OF CETUXIMAB TO OXALIPLATIN-BASED COMBINATION CHEMOTHERAPY (CT) IN PATIENTS WITH K-ras WILD-TYPE ADVANCED COLORECTAL CANCER (ACRC): EFFECTS ON OVERALL SURVIVAL. MRC COIN (CR10) TRIAL RESULTS
    por: Adams, R, et al.
    Publicado em: (2009)
  • THE ADDITION OF CETUXIMAB TO OXALIPLATIN-FLUOROPYRIMIDINE CHEMOTHERAPY IN FIRST-LINE ADVANCED COLORECTAL CANCER IN THE MRC COIN TRIAL: IDENTIFICATION OF POTENTIALLY RESPONSIVE SUBSETS OF PATIENTS
    por: Maughan, T, et al.
    Publicado em: (2010)
  • Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trial.
    por: Madi, A, et al.
    Publicado em: (2012)
  • Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: The MRC COIN trial
    por: Madi, A, et al.
    Publicado em: (2012)

Opções de Busca

  • Histórico de buscas
  • Busca Avançada

Encontrar Mais

  • Navegar o acervo
  • Navegar por ordem alfabética
  • Explorar canais
  • Bibliografia Recomendada
  • Novos itens

Precisa de ajuda?

  • Dicas de Busca
  • Serviço de Referência
  • Perguntas Frequentes